Samuel Augustus Nirmal

Samuel Augustus Nirmal

Active Director Director DIN 01722979
DIN 01722979 First appointment Mar 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 4 historical roles
Total affiliations 5 Since Mar 2004
Shareholding value •••• Premium profile

About Samuel Augustus Nirmal

Data last updated:

Samuel Augustus Nirmal is a Director at Schiefflin Institute Of Health-Research And Leprosy Centre (since 2022). The companies operate in Healthcare, Education and Financial Services. Schiefflin Institute Of Health-Research And Leprosy Centre reported revenue of ₹16.58 Cr (FY 2019). Earlier, Samuel Augustus Nirmal was a Director at Epalmleaf Ites Private Limited (2009–2019) and Director at Innovative Social Impact Foundation (2004–2009) and 2 more.

DIN 01722979
Primary Designation Director
Industry Healthcare
First Appointment 26 Mar 2004
Oldest Company Age 49 yrs
Largest company Schiefflin Institute Of Health-Research And Leprosy Centre · ₹16.58 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Sep 20221977₹16.58 Cr (FY 2019)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Epalmleaf Ites Private Limited U72200KA2009PTC049492
Director03 Jul 20092009₹54.1 Lakh (FY 2020)Active
Innovative Social Impact Foundation U88900TN2004NPL052754
Director26 Mar 20042004₹1.08 Cr (FY 2025)Active
Director25 Nov 20142008₹1.4 Lakh (FY 2020)Active
Director25 Apr 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Maaltus Social Ventures Private Limited
Schiefflin Institute Of Health-Research And Leprosy Centre
Epalmleaf Ites Private Limited
Innovative Social Impact Foundation
Premium access

Shareholding and investment profile for Samuel Augustus Nirmal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samuel Augustus Nirmal

Samuel Augustus Nirmal currently holds 1 directorship: Schiefflin Institute Of Health-Research And Leprosy Centre (Director, since 10 Sep 2022, revenue ₹16.58 Cr (FY 2019)).

Samuel Augustus Nirmal was first appointed on 26 Mar 2004 as Director at Innovative Social Impact Foundation. The most recent appointment on record is 10 Sep 2022 at Schiefflin Institute Of Health-Research And Leprosy Centre.

Samuel Augustus Nirmal held 4 earlier board appointments: Epalmleaf Ites Private Limited (Director, 03 Jul 2009 to 30 Mar 2019); Innovative Social Impact Foundation (Director, 26 Mar 2004 to 16 Jun 2009); Epalmleaf Consulting Services Private Limited (Director, 25 Nov 2014 to 30 Mar 2019); Maaltus Social Ventures Private Limited (Director, from 25 Apr 2013).

The current boards of Samuel Augustus Nirmal's companies include Arul Nelson Christadoss Jesudasen (Schiefflin Institute Of Health-Research And Leprosy Centre), Daniel Jeyakumar Vivian Peter (Schiefflin Institute Of Health-Research And Leprosy Centre), Jayanthi Abraham (Schiefflin Institute Of Health-Research And Leprosy Centre), Jerry Joshua (Schiefflin Institute Of Health-Research And Leprosy Centre), Matthan Kurian Ranjit (Schiefflin Institute Of Health-Research And Leprosy Centre), Paul Ravindran (Schiefflin Institute Of Health-Research And Leprosy Centre), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available